Addiction is a major health and social problem. The dopaminergic system is highly solicited by drugs of abuse, as an increased release of dopamine is a hallmark of the effect of drug intake. The dopamine D2 receptor (D2R) is a key component of the dopaminergic system. Indeed, in addition to its postsynaptic wide and abundant distribution in the central nervous system, it also functions as autoreceptor in the control of dopamine synthesis and release. D2Rs also modulate release of other neurotransmitters from postsynaptic neurons acting as a presynaptic heteroreceptor. D2Rs are composed in vivo by two isoforms, D2L and D2S, generated from the same gene by alternative splicing.
The aim of this proposal is to demonstrate that the presynaptic autoreceptor/heterosynaptic control mediated by dopamine D2 receptors exerts a principal role in the behavioral and cellular responses to drugs of abuse. This hypothesis is based on preliminary studies conducted in our laboratory showing that absence of D2 receptors signaling in mice (D2R-/-) strongly alters the response to psychostimulants and other abused drugs. On the contrary, in D2L-/- animals that do not express the D2L isoform of the receptor with postsynaptic functions (i.e. behavioral and cellular pharmacological responses to agonists/antagonists), but maintain the expression of the presynaptic/heterosynaptic receptor functions (i.e. control of DA release, cocaine-induced effects on striatal GABA electrophysiological effects), D2S, the motor and rewarding effects of drugs are intact. Both D2L and D2S are co-expressed, as a result of the alternative splicing of the D2R gene, thereby preventing a clear definition of the D2R role by the use of classical knockouts and/or by pharmacological tools. Thus, to achieve this aim we have generated conditional D2R mouse mutants, in which the selective ablation of D2R sites from dopaminergic or striatal neurons can be performed. Behavioral, biochemical and immunohistochemical studies are proposed to analyze loss of D2R site-specific effects when animals are exposed to the psychostimulant cocaine. Using these different approaches we will be able to determine the impact of loss of D2 receptors at the behavioral and cellular levels and possibly to identify the molecular mechanisms underlying the altered response to drugs of abuse found in D2R deficient mice. This research may lead to novel therapeutic intervention to treat addiction.

Public Health Relevance

Addiction to drugs of abuse is a major social and health problem. To be able to design therapeutic interventions to treat addiction, a detailed knowledge of the molecular mechanisms activated by drugs in the brain is requested. Through the analysis of sophisticated animal models, questions on how the neurotransmitter dopamine modifies brain activity in response to the psychostimulant cocaine will be addressed. This may lead to important new therapeutic developments. ? ? ?

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Research Project (R01)
Project #
Application #
Study Section
Molecular Neuropharmacology and Signaling Study Section (MNPS)
Program Officer
Pilotte, Nancy S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Irvine
Schools of Medicine
United States
Zip Code
Kharkwal, Geetika; Brami-Cherrier, Karen; Lizardi-Ortiz, José E et al. (2016) Parkinsonism Driven by Antipsychotics Originates from Dopaminergic Control of Striatal Cholinergic Interneurons. Neuron 91:67-78
Kharkwal, Geetika; Radl, Daniela; Lewis, Robert et al. (2016) Dopamine D2 receptors in striatal output neurons enable the psychomotor effects of cocaine. Proc Natl Acad Sci U S A 113:11609-11614
Brami-Cherrier, K; Anzalone, A; Ramos, M et al. (2014) Epigenetic reprogramming of cortical neurons through alteration of dopaminergic circuits. Mol Psychiatry 19:1193-200
Radl, Daniela; De Mei, Claudia; Chen, Eric et al. (2013) Each individual isoform of the dopamine D2 receptor protects from lactotroph hyperplasia. Mol Endocrinol 27:953-65
Anzalone, Andrea; Lizardi-Ortiz, José E; Ramos, Maria et al. (2012) Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors. J Neurosci 32:9023-34
Fulton, Stephanie; Thibault, Dominic; Mendez, Jose A et al. (2011) Contribution of Kv1.2 voltage-gated potassium channel to D2 autoreceptor regulation of axonal dopamine overflow. J Biol Chem 286:9360-72
Park, Eonyoung; Iaccarino, Ciro; Lee, Jiwon et al. (2011) Regulatory roles of heterogeneous nuclear ribonucleoprotein M and Nova-1 protein in alternative splicing of dopamine D2 receptor pre-mRNA. J Biol Chem 286:25301-8
Benoit-Marand, Marianne; Ballion, Bérangère; Borrelli, Emiliana et al. (2011) Inhibition of dopamine uptake by D2 antagonists: an in vivo study. J Neurochem 116:449-58
Sahar, Saurabh; Zocchi, Loredana; Kinoshita, Chisato et al. (2010) Regulation of BMAL1 protein stability and circadian function by GSK3beta-mediated phosphorylation. PLoS One 5:e8561
De Mei, Claudia; Ramos, Maria; Iitaka, Chisato et al. (2009) Getting specialized: presynaptic and postsynaptic dopamine D2 receptors. Curr Opin Pharmacol 9:53-8